Letters
Australian recommendations for the management of hepatocellular carcinoma
First published: 12 September 2021
No abstract is available for this article.
- 1Lubel JS, Roberts SK, Strasser SI, et al. Australian recommendations for the management of hepatocellular carcinoma: a consensus statement. Med J Aust 2021; 214: 475–483. https://www.mja.com.au/journal/2021/214/10/australian-recommendations-management-hepatocellular-carcinoma-consensus
- 2Lee YC, Cohet C, Yang YC, et al. Meta-analysis of epidemiologic studies on cigarette smoking and liver cancer. Int J Epidemiol 2009; 38: 1497–1511.
- 3Jee SH, Ohrr H, Sull JW, Samet JM. Cigarette smoking, alcohol drinking, hepatitis B, and risk for hepatocellular carcinoma in Korea. J Natl Cancer Inst 2004; 96: 1851–1856.
- 4Trichopolous D, Bamia C, Lagiou P, et al. Hepatocellular carcinoma risk factors and disease burden in a European cohort: a nested case-control study. J Natl Cancer Inst 2011; 103: 1686–1695.
- 5Hill C, Doyon F, Mousannif A. Évolution de la mortalité par cancer en France de 1950 à 2006 [Evolution of cancer mortality in France from 1950 to 2006]. Institut de Veille Sanitaire, 2009. https://www.santepubliquefrance.fr/docs/evolution-de-la-mortalite-par-cancer-en-france-de-1950-a-2006 (viewed Jan 2020).
